Member Info for beinthelead

What’s the point in this post if not to gloat and massage your ego?

CE mark isn’t affected.

It was very poor form to not inform the market and shareholders they were included. Hell, the Mologic CE IFU was update to REMOVE the antibody reference, I believe?

I very much doubt they’ll close. We are in a worse position than we were last week, even with the drop.

Hi Mcgurk, did you post this before today? Shame I missed it - I was looking out for your feedback. It’s the disaster nobody wanted, unfortunately.

Yes Rip, I’ll be here. This investment needs to be £20+ to be worth the effort and fulfil its potential.

Thanks - there’s few genuine folks left on here.

Totally mate.

Its increases my desire to leave the game, and my hope that Avacta succeeds in the shortest time possible. In reality, my investment will do what it needs to do. It’s inevitable that the trolls WILL impact it between now and my end.

Is it me, or are they out in force this weekend?

Some seriously disgraceful types. Why bother talking down a stock? Why does it matter so much to these people?

Answer; there is a finite amount of cash in this game. Trolling is a despicable discipline that is part of the new investing community.

Little to no wonder why equities are struggling so much. It’s literally a playground. And I mean that in reference to maturity.

Correct - the jealousy gives them away. It’s a torturous trait.

Weedylan - where is this quote taken from please: "Independent verified Cov-19 Technology combines all reagents in a Unique Design and integrates reporting of results."

I’d guess it’s referring to the not-for-profit test architecture, not ours.

:) you got me. I need that dose of realism.

I don’t meant to be rude; that was my point. Prof use test has little to no market. See previous post with AS quote. It’s self test going forward, hence my call for ABDX to manufacture MeduFlow.

Mologic designed our test with GAD manufacturing processes in mind. A constraint, I’d suggest. Therefore TT was not required.

Self test going forward which is the reason why I believe ABDX’s TT has been delayed for 25 years.

Yes.

We all know MeduFlow is a rebranded AffiDX, right???? Anyway, I’ll leave it there. Clearly not getting my point across.

Gmcc - just my opinion. Let’s wait and see.

Sorry, yes, I understand AffiDX and MeduFlow are the same thing.

By ‘not’ Affidx, I meant Meduflow. Which is essentially AffiDX with some IFU changes, QR’s etc.

ADBX will not be manufacturing AffiDX in my opinion.

AS has all but confirmed that the prof use test is no longer commercial. The delays would align.

“…As the pandemic progresses, the global antigen testing market is moving away from professional use antigen tests with increasing adoption of self-test.”products.

Thanks to Twitter: https://twitter.com/YorkshirPuddin/status/1479740328852832264?s=20

FDA certainly know how to align requirements to a problem. Perfectly simple process flow. Just need that online capacity confirmed… manufacturing capacity is the missing link on so many fronts. Let’s get it done.

We have open shorts at over 1% doggy. If this was a buy (as indicated), they’d be buying them back, I.e closing.

Either way, it looks interesting.

Hi Belgrano - absolutely. I truly believe this company is a unique proposition in terms of tech, and monetisation. I invested based on this.

I share your optimism in terms of company prospects, but perhaps more muted on the way communications have been made/lack of.

Again, apologies for any offence - I’m certainly not that kind.

Good idea: https://twitter.com/MrRipley21/status/1479423712806019073?s=20

Far more valuable than any HMG petitions.

Rip for CEO?